OClawVPS.com
Clear Labs
Edit

Clear Labs

http://clearlabs.com/
Last activity: 14.11.2025
Active
Categories: AnalyticsDataDiagnosticsFoodTechIndustryPlatformRoboticsScienceSoftwareSupply
Clear Labs was founded in 2013 by a group of software engineers and genomic scientists to enable dramatically stronger food safety and quality programs with comprehensive, genomics-based testing and cutting-edge data science.
Likes
14.34K
Followers
2.07K
Followers
6.75K
Website visits
7.9K /mo.
Mentions
60
Location: United States, California, San Carlos
Employees: 51-200
Phone: +1 650-462-1676
Total raised: $148.5M
Founded date: 2014

Investors 9

Funding Rounds 6

DateSeriesAmountInvestors
21.02.2025Series D$30M-
26.05.2021Series C$60MT. Rowe Pr...
14.05.2020-$18M-
30.10.2018Series B$21M-
15.12.2016Series B$13MGV
15.09.2015Series A$6.5M-

Mentions in press and media 60

DateTitleDescription
14.11.2025Clear Labs Showcases Oncology NGS Automation Initiatives and Announces Collaboration with LabcorpClear Labs announced its expanded automation platform and collaboration with Labcorp to develop streamlined, oncology-focused NGS workflows, marking its move beyond infectious disease sequencing and toward scalable, in-house genomic testing...
13.11.2025Clear Labs Unveils Automated Workflow Featuring Pillar Biosciences' SLIMamp® Technology at AMP 2025Clear Labs announced a new automated workflow featuring Pillar Biosciences' SLIMamp® chemistry on the Clear Dx™ platform, debuting at the AMP Annual Meeting. The collaboration expands Clear Labs' automation technology into oncology, enablin...
26.08.2025Clear Labs Launches Clear Dx™ Deeplex® Myc-TB, An Automated Solution for Mycobacterium Species Identification and TB Drug Resistance MutationsClear Labs Clear Labs and GenoScreen introduce Clear Dx™ Deeplex® Myc-TB, an automated next-day solution for rapid TB and NTM identification with drug resistance insights. SAN CARLOS, Calif., Aug. 26, 2025 /PRNewswire-PRWeb/ -- Clear Labs, ...
04.06.2025Clear Labs Launches New Fully Automated NGS Platform for Rapid Bacterial and Fungal Detection from Sterile Site SpecimensClear Labs logo Clear Labs introduces an automated NGS assay that identifies bacteria and fungi from sterile site specimens with next-day results and minimal hands-on time. SAN CARLOS, Calif., June 4, 2025 /PRNewswire-PRWeb/ -- Clear Labs, ...
21.02.2025Clear Labs Secures $30 Million in Series D Financing to Accelerate Development and Adoption of Cutting-Edge Sequencing SolutionsClear Labs, a provider of fully automated and next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it secured $30 million in its Series D financing. The funding round was led by a strategic investor, along with part...
16.01.2025Clear Labs: $30 Million (Series D) Secured For Advancing Development Of Sequencing SolutionsClear Labs, a provider of fully automated and next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it has raised $30 million in its Series D financing. This funding round was led by a strategic investor, along with ...
13.01.2025Clear Labs Raises $30M in Series D FinancingClear Labs, a San Carlos, CA-based provider of next-generation sequencing (NGS) platforms for diagnostics, raised $30M in Series D funding. The round was led by a strategic investor, along with participation from existing investors, includi...
13.01.2025Clear Labs Secures $30 Million in Series D Financing to Accelerate Development and Adoption of Cutting-Edge Sequencing SolutionsClear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for the clinical and applied markets. Leader in Next-Generation Sequencing Advances Innovation in Healthcare with Capital and Appointment of ...
11.10.2023MDisrupt raises $3M seed to bring medical expertise to healthtech innovatorsIt's the people, platform, and data that make a successful product These days, you don’t have to have a medical degree to develop innovative health technology. But you still need lots of in-depth medical intelligence. Well, for that, you ca...
28.09.2023Bytes to Bites part two – From farm to fork: Leveraging AI in the food supply chainEditor’s Note: Eva Everloo is senior investment analyst, and Anina Troya is an investment analyst intern at agri-food tech investor PeakBridge. The views expressed in this guest commentary are the authors’ own and do not necessarily reflect...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In